Marta Telishevska, Sarah Lengauer, Tilko Reents, Verena Kantenwein, Miruna Popa, Fabian Bahlke, Florian Englert, Nico Erhard, Isabel Deisenhofer, Gabriele Hessling
BACKGROUND: The aim of this study was to assess long-term efficacy and safety of empirical slow pathway (ESP) ablation in pediatric and adult patients with a special interest in patients without dual AV nodal physiology (DAVNP). METHODS: A retrospective single-center review of patients who underwent ESP ablation between December 2014 and September 2022 was performed. Follow-up included telephone communication, letter questionnaire and outpatient presentation. Recurrence was based on typical symptoms...
October 15, 2023: Journal of Clinical Medicine